Giving evidence of success

03 July 2015
Volume 31 · Issue 6

A key theme of EuroPerio8 was the importance of providing quality products and education to enable patients in their journey towards optimal oral health.

GSK joined the discussion with an interactive symposium ‘Can we reverse gingivitis in the 21st century?’ considering the significance of recommending chemical plaque control as a vital adjunct to mechanical or manual cleaning. Delegates were invited to use remote devices to register their opinions regarding important elements around oral health, including their own recommendations for patients. This method highlighted the difference of opinion across the board and encouraged debate around the subject. The vote revealed that 95 per cent of professionals believed that managing gingivitis is important to oral health and 53 per cent agreed that giving oral hygiene advice significantly reduces rates. Around 40 per cent would recommend using a mouthwash/antiseptic to help manage gingivitis, whilst 53 per cent recommend using a chlorhexidine product for treatment. Delegates agreed that treating gingivitis early can help prevent a more serious condition developing, which may impact quality of life.

Evidence suggests that mechanical plaque removal alone may not be sufficient to remove oral biofilm, to prevent its recurrence, or to reach all areas of the mouth. Antimicrobial mouth rinses can be used in addition to tooth brushing for plaque control or as a replacement for those who have difficulties brushing.

Niklaus Lang, of the University of Hong Kong, speaking at the interactive GSK sponsored symposium reflected on how important this often overlooked element of the oral care routine is, and what a massive difference it can have on the successful treatment of gingivitis.

In particular, Niklaus put forward a case for the use of chlorhexidine, as a microbial with over forty years of clinical evidence behind it.

After the event, Soha Dattani, GSK Area Medical Director for Great Britain and Ireland, expressed how motivating the whole conference had been and how important it is to have a dialogue between product developers and the clinicians using and endorsing the products. The question posed in the session’s title provoked discussion among the delegates over what steps need to be taken in order to make a significant impact on the treatment of gum disease at the gingivitis stage, thereby preventing the development of periodontitis; for Soha, using and recommending products with a body of clinical evidence behind them is the place to start.